Treatment of Iron Deficiency Anaemia in Pregnancy Study
Launched by THE ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST · Oct 29, 2018
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women (any stage during pregnancy up to 36 weeks) and women in the puerperium (within 6 weeks postdelivery) with anaemia as defined by World Health Organization (WHO) criteria and described in British Society Haematology (BSH)/ British Committee for standards in Haematology (BCSH) guidelines.
- • 1. First trimester \< 110g/l
- • 2. Second and third trimester \< 105g/l
- • 3. Puerperium \< 100g/l
- • Age: 18-45 years
- • Agreement to participate in the study with consenting
- Exclusion Criteria:
- • Anaemic women presenting at or after 36 weeks as there may be insufficient time to delivery to assess responses to oral iron)
- • Anaemic women affected by a (major) haemoglobinopathy e.g. B thalassaemia major sickle cell disease
- • Women with overt clinical signs of sepsis
- • Allergies to iron
- • Hyperemesis Gravidarum / persistent vomiting
- • Women with inflammatory conditions such as Crohns, ulcerative colitis, Systemic lupus erythematosus, Rheumatoid arthritis.
- • Women with chronic renal failure
About The Royal Wolverhampton Hospitals Nhs Trust
The Royal Wolverhampton Hospitals NHS Trust is a leading healthcare provider in the West Midlands, dedicated to delivering high-quality patient care and advancing medical research through clinical trials. As a prominent NHS trust, it encompasses a range of specialized services across multiple hospitals, focusing on innovation and evidence-based practices. The Trust actively engages in clinical research to enhance treatment options and improve patient outcomes, fostering collaboration among healthcare professionals, researchers, and academic institutions. Committed to patient safety and ethical standards, the Royal Wolverhampton Hospitals NHS Trust plays a pivotal role in advancing healthcare through rigorous clinical trials and research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wolverhampton, , United Kingdom
Wolverhampton, West Midlands, United Kingdom
Patients applied
Trial Officials
David Churchill
Principal Investigator
The Royal Wolverhampton NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials